# Safety and Activity of Flotetuzumab in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia: Results from the COG PEPN1812 Phase 1 Trial

> Research article (Blood, 2022) · cited 14× · AI/ML

**Wikidata**: [openalex:W4310157901](https://www.wikidata.org/wiki/openalex:W4310157901)  
**Source**: https://4ort.xyz/entity/safety-and-activity-of-flotetuzumab-in-pediatric-and-young-adult-patients-with-relapsed-refractory-acute-myeloid-leukemi